Article
PDGFRB as a potential therapeutic target of ankylosing spondylitis: validation following bioinformatics analysis
30 Sept 2020
Abstract excerpt
Ankylosing spondylitis (AS) is a chronic, progressive, and inflammatory disease that mainly affects the central axis joint. Although this disease has already been well documented and studied, its pathogenesis is still not well understood. This study aimed to screen and identify key candidate genes involved in the progression of AS. For this purpose, expression profiles of GSE39340 and GSE41038 were downloaded...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
